The DCU MSc in Biotherapeutics (NFQ Level 9) is the first postgraduate programme in the world providing education and training specifically focusing on biotherapeutics across cancer, neuro, immune and cardiovascular diseases within a unique setting offering access to the core Microbial Bioprocess Engineering (MBF) and GMP-like Manufacturing facilities as well as the state-of-the-art facilities at National Institute for Bioprocessing Research and Training (NIBRT).

The programme will offer a broad multidisciplinary approach with a strategic and sustainable focus on development, production, licensing and delivery of biotherapeutics. The programme aims to provide training and education in immunology, oncology, vascular biology, and neuropathology, and to foster key skills for the development and scalable manufacture of novel biotherapeutics to improve patient outcomes and healthcare delivery. Additionally, the programme aims to develop students’ critical analysis skills, enhance their professional development and to provide them with skills necessary to undertake independent scientific research or gain employment/promotion in the BioPharmaceutical industry.